That rationale must be backed by non-clinical data confirming the compound behaves as expected and by a thorough safety and toxicology program that identifies potential risks and establishes a safe starting dose for the first human administration and the maximum human exposure that should not be surpassed
Recalls & Warnings September 05, 2014 Seller of "Nerve", "Cleanse" and Probiotic Supplements Warned for Drug Claims On July 30, 2014, the FDA issued a warning letter to Plexus Worldwide, Inc., following a review of the company's website and product labels, which found statements made about Fast Relief, BioCleanse and ProBio5 to be drug claims
By offering clear specifications, complete documentation (COA, MSDS, and related certificates), competitive pricing, and flexible order arrangements, Runtai Chemical can support manufacturers and brand owners worldwide in developing highquality glutathionebased formulations in pharmaceuticals, supplements, cosmetics, and functional foods
The survey data did not specify timeline to improvement